Bolden Therapeutics Employee Directory

Biotechnology ResearchRhode Island, United States2-10 Employees

Bolden Therapeutics is a biotechnology company focused on developing therapies for central nervous system diseases, including Alzheimer's disease and ischemic stroke. It seeks to address the biology of the brain by stimulating neural stem cells to promote neurogenesis in the adult brain. In a proprietary mouse model, the company has demonstrated proof-of-concept that activating this pathway increases neurogenesis and can enhance hippocampus-dependent memory. Based in Providence, Rhode Island, Bolden is described in recent coverage as a Brown University spinoff. The company maintains a small team and is pursuing therapeutic approaches aimed at modulating the identified neural pathway. Its positioning places it in the biotechnology research sector focused on CNS therapeutics, with a translational emphasis from preclinical insight toward potential treatments.

Sign up for free to view info

Company overview Email format